Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ulrich Niewöhner is active.

Publication


Featured researches published by Ulrich Niewöhner.


Archive | 1997

New heterocyclylmethyl-substituted pyrazol derivates

Alexander Straub; Chantal Fürstner; Ulrich Niewöhner; Thomas Jaetsch; Achim Feurer; Raimund Kast; Johannes-Peter Stasch; Elisabeth Perzborn; Joachim Hütter; Klaus Dembowsky; Dieter Arlt


Bioorganic & Medicinal Chemistry Letters | 2005

Comparison of different heterocyclic scaffolds as substrate analog PDE5 inhibitors.

Helmut Haning; Ulrich Niewöhner; Thomas Schenke; Thomas Lampe; Alexander Hillisch; Erwin Bischoff


Archive | 2001

Selective pde 2 inhibitors, used as medicaments for improving cognition

Frank-Gerhard Böss; Martin Hendrix; Gerhard Konig; Karl-Heinz Schlemmer; R. Schreiber; Der Staay Franz-Josef Van; Dagmar Schauss; Ulrich Niewöhner


Archive | 2003

Heterocyclically substituted imidazotriazines

Martin Hendrix; David Brückner; Arno Friedl; Irene Gerlach; Volker Hinz; Jörg Keldenich; Frank Mauler; Ulrich Niewöhner; Maria Theresia Niewohner; Dagmar Karthaus; Karl-Heinz Schlemmer; Adrian Tersteeger; Ozkan Yalkinoglu


Archive | 2005

Use of 2-alkoxyphenyl-substituted imidazotriazinones

Ulrich Niewöhner; Maria Theresia Niewohner; Erwin Bischoff; Helmut Haning; Afssaneh Rahbar; Tiemo‐Joerg Bandel; Wolfgang Barth


Archive | 2004

Imidazo[1,3,5]triazinones and their use

Ulrich Niewöhner; Helmut Haning; Thomas Lampe; Mazen Es-Sayed; Gunter Schmidt; Erwin Bischoff; Klaus Dembowsky; Elisabeth Perzborn; Karl-Heinz Schlemmer


Archive | 2002

Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases

Cristina Alonso-Alija; Heike Gielen; Martin Hendrix; Dagmar Schauss; Hilmar Bischoff; Nils Burkhardt; Volker Geiss; Karl-Heinz Schlemmer; Nigel Cuthbert; Mary F. Fitzgerald; Graham Sturton; Ulrich Niewöhner


Archive | 2001

Novel substituted imidazotriazinones as pde ii-inhibitors

Dagmar Schauss; Martin Hendrix; Gerhard Konig; Frank-Gerhard Böss; Der Staay Franz-Josef Van; R. Schreiber; Karl-Heinz Schlemmer; Rolf Grosser; Ulrich Niewöhner


Archive | 2002

2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases

Cristina Alonso-Alija; Heike Gielen; Martin Hendrix; Ulrich Niewöhner; Maria Theresia Niewohner; Dagmar Schauss; Hilmar Bischoff; Nils Burkhardt; Volker Geiss; Karl-Heinz Schlemmer; Nigel Cuthbert; Mary F. Fitzgerald; Graham Sturton


Archive | 2003

5-ethyl-imidazo (5,1-f) (1,2,4,) triazin-4 (3h) -ones as phosphodiesterase inhibitors

Cristina Alonso-Alija; Heike Gielen-Haertwig; Martin Michels; Dagmar Karthaus; Hilmar Bischoff; Nils Burkhardt; Volker Geiss; Karl-Heinz Schlemmer; Nigel Cuthbert; Mary F. Fitzgerald; Graham Sturton; Ulrich Niewöhner

Collaboration


Dive into the Ulrich Niewöhner's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge